Anderson details how ACD/Labs ensures that data are AI-ready and FAIR-compliant across diverse systems common in pharma R&D.

Eli Lilly and Company plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama.

As we step into 2026, the AI and analytics story for health care and life sciences isn't about sudden disruption -- it's about a steady, strategic evolution toward smart, practical innovation. The ...

Medra, a company developing a platform for Physical AI Scientists, has announced a $52 million Series A financing led by ...

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered ...

PREVIOUS COVERAGE - Pharmaceutical giant Eli Lilly and Company announced Tuesday a massive $6 billion investment to build a ...

Eli Lilly and Company announced Tuesday, Dec. 9 plans to invest more than $6 billion in a new manufacturing facility in ...

ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced a major expansion of its operations with the addition of new clean rooms, automation, and robotic technologies- ...

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.

Artificial intelligence chemistry outfit Excelsior Sciences is gaining ground on its quest to hasten the discovery and production of small molecules. | Excelsior Sciences, which spun out of investment ...